Common Stock, Shares, Issued of Innovation1 Biotech Inc. from 10 Nov 2014 to 29 Feb 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Innovation1 Biotech Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 10 Nov 2014 to 29 Feb 2024.
  • Innovation1 Biotech Inc. Common Stock, Shares, Issued for the quarter ending 29 Feb 2024 was 22,470,239, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Innovation1 Biotech Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 22,470,239 +2,450,000 +12% 29 Feb 2024 10-Q 06 May 2025 2024 Q2
Q4 2023 22,470,239 +2,450,000 +12% 30 Nov 2023 10-Q 27 Jan 2025 2023 Q1
Q3 2023 20,470,239 +450,000 +2.2% 31 Aug 2023 10-Q 06 May 2025 2024 Q2
Q2 2023 20,470,239 +450,000 +2.2% 31 May 2023 10-Q 13 Sep 2023 2023 Q3
Q1 2023 20,020,239 0 0% 28 Feb 2023 10-Q 30 May 2023 2023 Q2
Q4 2022 20,020,239 0 0% 30 Nov 2022 10-Q 17 Jan 2023 2023 Q1
Q3 2022 20,020,239 +19,831,623 +10514% 31 Aug 2022 10-K 17 Jan 2024 2023 FY
Q2 2022 20,020,239 +19,831,623 +10514% 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 20,020,239 +19,831,623 +10514% 28 Feb 2022 10-Q 15 Apr 2022 2022 Q2
Q4 2021 20,020,239 +19,833,045 +10595% 30 Nov 2021 10-Q/A 01 Feb 2022 2022 Q1
Q3 2021 188,616 +1,422 +0.76% 31 Aug 2021 10-K 15 Dec 2022 2022 FY
Q2 2021 188,616 -57,448,104 -100% 31 May 2021 10-Q 13 Jul 2021 2021 Q3
Q1 2021 188,616 -57,448,104 -100% 28 Feb 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 187,194 -135,322,026 -100% 30 Nov 2020 10-Q 13 Jan 2021 2021 Q1
Q3 2020 187,194 -135,093,457 -100% 31 Aug 2020 10-K 10 Dec 2021 2021 FY
Q2 2020 57,636,720 -76,363,410 -57% 31 May 2020 10-Q 20 Jul 2020 2020 Q3
Q1 2020 57,636,720 -75,467,823 -57% 29 Feb 2020 10-Q 20 Apr 2020 2020 Q2
Q4 2019 135,509,220 +2,871,720 +2.2% 30 Nov 2019 10-Q 21 Jan 2020 2020 Q1
Q3 2019 135,280,651 +2,643,151 +2% 31 Aug 2019 10-K 15 Dec 2020 2020 FY
Q2 2019 134,000,130 +1,134,059 +0.85% 31 May 2019 10-Q 18 Jul 2019 2019 Q3
Q1 2019 133,104,543 +238,472 +0.18% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 132,637,500 -85,715 -0.06% 30 Nov 2018 10-Q 18 Jan 2019 2019 Q1
Q3 2018 132,637,500 +70,000,000 +112% 31 Aug 2018 10-K 17 Dec 2019 2019 FY
Q2 2018 132,866,071 +80,228,571 +152% 31 May 2018 10-Q 23 Jul 2018 2018 Q3
Q1 2018 132,866,071 +80,228,571 +152% 28 Feb 2018 10-Q 23 Apr 2018 2018 Q2
Q4 2017 132,723,215 +80,085,715 +152% 30 Nov 2017 10-Q 22 Jan 2018 2018 Q1
Q3 2017 62,637,500 +10,000,000 +19% 31 Aug 2017 10-K 14 Dec 2018 2018 FY
Q2 2017 52,637,500 0 0% 31 May 2017 10-Q 24 Jul 2017 2017 Q3
Q1 2017 52,637,500 0 0% 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 52,637,500 +47,637,500 +953% 30 Nov 2016 10-Q 17 Jan 2017 2017 Q1
Q3 2016 52,637,500 +20,137,500 +62% 31 Aug 2016 10-K/A 19 Jan 2018 2017 FY
Q2 2016 52,637,500 31 May 2016 10-Q 07 Oct 2016 2016 Q3
Q1 2016 52,637,500 15 Mar 2016 10-K/A 19 Jan 2018 2017 FY
Q4 2015 5,000,000 30 Nov 2015 10-Q 12 Feb 2016 2016 Q1
Q3 2015 32,500,000 -1,217,500,000 -97% 31 Aug 2015 10-K 06 Dec 2016 2016 FY
Q3 2014 1,250,000,000 10 Nov 2014 10-Q 17 Jan 2017 2017 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.